DrugDev

About DrugDev

DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.

DrugDev was founded in 2009 by Melissa Easy after identifying inefficiencies in the process of matching clinical trial doctors (investigators) to pharmaceutical protocols. The company started with a network of cardiologists, and has since grown through referral and invitation into the world's largest investigator network and data sharing platform, today reaching more than 80,000 active investigators in 125 countries, all of whom have interest in clinical trial opportunities. The company is headquartered in Wayne, PA. For more information, visit drugdev.com.

Contact Information

Cindy Murray
Director of Marketing
DrugDev
1170 Devon Park Drive
Suite 300
Wayne, PA 19087
USA
(610) 650-1890
Solutions@DrugDev.com
www.drugdev.com
View Map

Clients

DrugDev offers services to:

  • Biopharmaceutical Sponsors
  • Clinical Research Organizations
  • Investigators

Services Offered

DrugDev's unified solutions suite optimizes site selection and startup through SiteStart, investigator payments and tax consulting through DrugDev Payments, and clinical operations through TrialNetworks. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials.

SiteStart

DrugDev manages the industry's largest global network of opted-in investigators who are actively seeking new clinical trial opportunities. DrugDev SiteStart leverages this exclusive resource to identify sites that are ideal matches for each protocol and have the best chance for success.

Once sites have been selected, DrugDev accelerates the activation process with technology and services for executing clinical trial agreements and collecting essential regulatory documents with full transparency.

Service Features:

  • Access to 80,000 investigators across 124 countries that are actively seeking new trial opportunities
  • Improve protocol feasibility by reducing risk and soliciting feedback from expert investigators early in the startup process
  • Gain higher response rates with DrugDev’s multilingual team that maintains regular contact with sites
  • Ensure compliance with current Fair Market Value guidance by having DrugDev's seasoned professionals develop the investigator grant using IMS Health GrantPlan® and our comprehensive proprietary database of procedures and costs
  • Gain complete transparency into the CTA negotiation process as DrugDev creates, negotiates and executes CTAs using our innovative technology platform that provides you with real time access to the status of each negotiation
  • Ensure that your site activation documents are submission ready by taking advantage of our robust quality management system that features multi-tier QC review, automated tracking of expiring documents, and GCP compliant standard operating procedures

Service Benefits:

  • Accelerate cycle times: Robust site profiles allow DrugDev staff to leverage precious negotiations and current essential documents on file which eliminates redundancy and maximizes the number of activated, "enrollment-ready" sites when the trial begins
  • Find Investigators: DrugDev customers leverage strong relationships to identify investigators with very specific expertise, find research naive investigators with abundant eligible patient pools, and react to rapidly changing geopolitical challenges
  • Protocol feasibility: DrugDev is uniquely positioned to leverage existing investigator relationships and SiteCloud technology to rapidly capture feedback from global investigators
  • Process Automation: Our innovative technology automates key aspects of the cumbersome site activation process which streamlines document collection, improves investigator satisfaction, and alleviates the burden to your project team so they can focus on more strategic clinical trial activities instead of chasing after busy site personnel

Payments

With an unprecedented $1 billion of site payments processed, DrugDev Payments (formerly CFS Clinical) is the leading specialized provider of investigator payments. Our proven technology and experience ensures site satisfaction with accurate, timely and reliable payments.

Featuring comprehensive aggregate spend reporting for Sunshine Act and regulatory compliance along with global tax services to minimize financial burden, DrugDev is the payments provider that sponsors and CROs trust most.

Service Features:

  • Timely, accurate and reliable investigator payments
  • Aggregate spending reports for transparency and Sunshine Act compliance
  • Global tax strategies optimized by country
  • Expert guidance from a proven payments team to manage the complexity of global grant payments, including local tax implications and risk around the world
  • Robust monthly reporting and forecasting to better manage your trial budget
  • Investigator access to payment records in their local language and currency
  • Incentivized payment schedules based on integrated EDC data to financially motivate sites to enter data quickly and accelerate milestone timelines

Service Benefits:

  • Financial control and compliance: DrugDev’s innovative technology and demanding processes allow clients to precisely calculate monthly spend. With that insight, organizations can make just-in-time payments and better manage trial budgets. Accurate, real-time accruals and reporting enhance business intelligence - while electronic billing transactions and straight-through processing enable superior financial control
  • Enhance investigator relationships: DrugDev’s automated data extraction process allows us to meet investigators’ expectations for prompt, accurate, and transparent payments. Outside North America, DrugDev’s advanced invoicing process and payment tracking further eases our clients’ site burden. Investigators are guided with automated alerts to our site portal to see details of their payments
  • Accelerate cycle times: Because we extract payments from EDC data (e.g. Medidata Rave®), investigative sites are incentivized to input data quickly, ultimately providing trial results faster

TrialNetworks

The TrialNetworks study platform by DrugDev is an innovative cloud-based clinical trial optimization system featuring a unified suite of trial management apps and site-facing tools to transform quality and efficiency. Awarded Disruptive Technology of the Year in 2014, the platform provides collaborative solutions for site engagement, training, critical process tracking, document management, feasibility surveys, activation and closeout.

Service Features:

Workflow Optimization

  • Charting - Dynamic visual reports to track progress by region/country/site
  • Checklist - Collaborative task roadmap to speed activation and closeout
  • Document Library - Secure repository for sharing and tracking study docs
  • Directory - Active community of sites, key study contacts, CROs and vendors
  • Survey - Intuitive and structured surveys for site feasibility and feedback Site engagement
  • News - Engaging stories and updates to keep your trial top of mind at global sites
  • Leaderboard - Ranks sites on key metrics to inspire friendly competition
  • Badging - Recognition for sites in front of peers as they achieve key milestones Learning management
  • Training - Multimedia training modules, assessments, reporting and certificates
  • Visit Guide - A visual protocol guide with helpful calculators for site staff
  • FAQ - Searchable information to help sites quickly get the answers they need

Service Benefits:

  • Optimize clinops processes
  • Train and support sites
  • Keep sites engaged

Data Solutions

Making sense of investigator and site data is a significant challenge. In Data Solutions, our SiteCloud platform integrates data from multiple disparate sources to create a reliable database of matched and mastered records using the industry-adopted universal identifier called the DrugDev Number. SiteCloud features robust search capabilities and outreach tools which enable sponsors and CROs to make - and take action on - informed site selection decisions.

DrugDev also serves as the trusted third-party host of the Investigator Databank collaboration and powers the TransCelerate Investigator Registry.

Service Features:

  • Match and master investigator and site records to create a clean and actionable resource that can be used to make evidence-based site selection decisions with the industry-adopted universal identifier called the DrugDev Golden Number
  • SiteCloud features an intuitive interface, robust search capabilities, permission-based views and outreach tools to ensure sponsors and CROs are able to take action on more informed site selection decisions

Service Benefits:

  • Improved country selection and more realistic recruitment projections
  • Less time spent prioritizing/ selecting investigators
  • Reduced rescue sites potentially needed
  • Decreased costs and time associated with start-up of rescue sites
  • Fewer non-performing and under-performing sites
  • Decreased IT time and costs of investigator and site data mastering
  • Potential for tracking of investigators and sites across multiple systems (e.g. Payments, TrialNetworks, CTMS, EDC)

Contact Information

Cindy Murray
Director of Marketing
DrugDev
1170 Devon Park Drive
Suite 300
Wayne, PA 19087
USA
(610) 650-1890
Solutions@DrugDev.com
www.drugdev.com
View Map

Contact Company

If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.